These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18267354)

  • 21. Invivo antioxidant status: a putative target of antidepressant action.
    Zafir A; Ara A; Banu N
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):220-8. PubMed ID: 19059298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory mechanisms in major depressive disorder.
    Raedler TJ
    Curr Opin Psychiatry; 2011 Nov; 24(6):519-25. PubMed ID: 21897249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Confirmation of antidepressant potential of the selective beta3 adrenoceptor agonist amibegron in an animal model of depression.
    Overstreet DH; Stemmelin J; Griebel G
    Pharmacol Biochem Behav; 2008 Jun; 89(4):623-6. PubMed ID: 18358519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New approaches to antidepressant drug discovery: beyond monoamines.
    Berton O; Nestler EJ
    Nat Rev Neurosci; 2006 Feb; 7(2):137-51. PubMed ID: 16429123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ascorbic acid administration produces an antidepressant-like effect: evidence for the involvement of monoaminergic neurotransmission.
    Binfaré RW; Rosa AO; Lobato KR; Santos AR; Rodrigues AL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):530-40. PubMed ID: 19439241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmenting antidepressants with folate: a clinical perspective.
    Fava M
    J Clin Psychiatry; 2007; 68 Suppl 10():4-7. PubMed ID: 17900202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minocycline does not evoke anxiolytic and antidepressant-like effects in C57BL/6 mice.
    Vogt MA; Mallien AS; Pfeiffer N; Inta I; Gass P; Inta D
    Behav Brain Res; 2016 Mar; 301():96-101. PubMed ID: 26698398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antidepressants and pain.
    Micó JA; Ardid D; Berrocoso E; Eschalier A
    Trends Pharmacol Sci; 2006 Jul; 27(7):348-54. PubMed ID: 16762426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Is good old minocycline a new neuroprotective drug?].
    Melero-Fernández de Mera RM; García-Martínez E; Fernández-Gómez FJ; Hernández-Guijo JM; Aguirre N; Galindo MF; Jordán J
    Rev Neurol; 2008 Jul 1-15; 47(1):31-8. PubMed ID: 18592478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tramadol in the rat forced swimming test.
    Jesse CR; Bortolatto CF; Savegnago L; Rocha JB; Nogueira CW
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1838-43. PubMed ID: 18773934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advances in antidepressants and research methods of depression].
    Yang XY; Chen J; Yang XM; Ma SP
    Zhongguo Zhong Yao Za Zhi; 2007 May; 32(9):770-4. PubMed ID: 17639970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging treatments for major depression.
    Norman TR; Burrows GD
    Expert Rev Neurother; 2007 Feb; 7(2):203-13. PubMed ID: 17286553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
    Engin E; Treit D; Dickson CT
    Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interest of using genetically manipulated mice as models of depression to evaluate antidepressant drugs activity: a review.
    Gardier AM; Guiard BP; Guilloux JP; Repérant C; Coudoré F; David DJ
    Fundam Clin Pharmacol; 2009 Feb; 23(1):23-42. PubMed ID: 19267769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressant-like effects of the CRF family peptides, urocortin 1, urocortin 2 and urocortin 3 in a modified forced swimming test in mice.
    Tanaka M; Telegdy G
    Brain Res Bull; 2008 Mar; 75(5):509-12. PubMed ID: 18355626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidepressive-like effects of rapamycin in animal models: Implications for mTOR inhibition as a new target for treatment of affective disorders.
    Cleary C; Linde JA; Hiscock KM; Hadas I; Belmaker RH; Agam G; Flaisher-Grinberg S; Einat H
    Brain Res Bull; 2008 Jul; 76(5):469-73. PubMed ID: 18534253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuating effects of testosterone on depressive-like behavior in the forced swim test in healthy male rats.
    Buddenberg TE; Komorowski M; Ruocco LA; Silva MA; Topic B
    Brain Res Bull; 2009 May; 79(3-4):182-6. PubMed ID: 19429189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 3beta-hydroxysteroid dehydrogenase inhibitor trilostane shows antidepressant properties in mice.
    Espallergues J; Givalois L; Temsamani J; Laruelle C; Maurice T
    Psychoneuroendocrinology; 2009 Jun; 34(5):644-59. PubMed ID: 19117688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral inflammation contributes to encephalopathy and brain edema in acute liver failure: protective effect of minocycline.
    Jiang W; Desjardins P; Butterworth RF
    J Neurochem; 2009 Apr; 109(2):485-93. PubMed ID: 19220703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacological characterization and mechanisms of the novel antidepressive- and/or anxiolytic-like substances identified from Perillae Herba].
    Tsuji M; Miyagawa K; Takeuchi T; Takeda H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):159-67. PubMed ID: 18800619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.